CAW
AGIO icon

Cornerstone Advisors (Washington)’s Agios Pharmaceuticals AGIO Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-99
Closed -$5K – 789
2019
Q2 		$5K Buy
99
+30
+43% +$1.6K ﹤0.01% 905
2019
Q1 		$5K Hold
69
– – ﹤0.01% 820
2018
Q4 		$3K Buy
+69
New +$4.26K ﹤0.01% 818
2016
Q3 		– Sell
-122
Closed -$5K – 917
2016
Q2 		$5K Hold
122
– – 0.01% 551
2016
Q1 		$5K Hold
122
– – 0.01% 549
2015
Q4 		$8K Hold
122
– – 0.01% 476
2015
Q3 		$9K Buy
+122
New +$11.9K 0.01% 463

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Cornerstone Advisors (Washington)'s AGIO Position: Q3 2019 in Review

Cornerstone Advisors (Washington) sold out of Agios Pharmaceuticals (AGIO) in Q3 2019, closing a stake of 99 shares — an estimated $5K sold.

Cornerstone Advisors (Washington) first reported a position in AGIO in Q3 2015 and held it in 7 quarters. The position peaked at $9K in Q3 2015. 189 funds tracked by Wall St. Rank hold AGIO as of Q3 2019.

  • Cornerstone Advisors (Washington) reported no remaining Agios Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Cornerstone Advisors (Washington) sold 99 Agios Pharmaceuticals shares in Q3 2019, an estimated $5K.
  • Cornerstone Advisors (Washington) first reported a position in Agios Pharmaceuticals in Q3 2015 and held it in 7 quarters.
  • Cornerstone Advisors (Washington)'s Agios Pharmaceuticals position peaked at $9K in Q3 2015.
  • 189 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2019.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2019, filed 23 Oct 2019.